A new era of podocyte-targeted therapy for proteinuric kidney disease

N Engl J Med. 2013 Dec 19;369(25):2453-4. doi: 10.1056/NEJMe1312835. Epub 2013 Nov 8.

Author

Börje Haraldsson¹

Affiliation

¹ From the Institute of Medicine, University of Gothenburg, Gothenburg, Sweden; and the Department of Medicine, Icahn School of Medicine at Mount Sinai, New York.

PMID: 24206429
DOI: 10.1056/NEJMe1312835

No abstract available

Publication types

Editorial
Comment

MeSH terms

Abatacept
B7-1 Antigen / metabolism*
Female
Glomerulosclerosis, Focal Segmental / drug therapy*
Humans
Immunoconjugates / pharmacology*
Male

Substances

B7-1 Antigen
Immunoconjugates
Abatacept